When Dropbox wanted to advertise their product, "Dropbox Paper," they were looking to tap into the young creatives market. Dropbox turned to The California Sunday Magazine, but instead of taking out an ad in their paper, Dropbox went a more creative route by creating an ad that illustrates the process of using Dropbox Paper. Dropbox Paper teamed up with the weekend magazine to show how creatives can collaborate from all corners of the world through the cloud. The project resulted in three unique films, created by 25 individuals, across 3 continents, and 6 different time zones. These team members never met, but were still able to create together. Chas Edwards, President and Publisher of The California Sunday Magazine, joins Cheddar to explain how this initiative is an illustration of where the advertising world is going. Consumers don't want to be served ads, they want to consume more content.

Share:
More In Business
Poll: More Americans think companies benefit from legal immigration
A new poll finds U.S. adults are more likely than they were a year ago to think immigrants in the country legally benefit the economy. That comes as President Donald Trump's administration imposes new restrictions targeting legal pathways into the country. The Associated Press-NORC Center for Public Affairs Research survey finds Americans are more likely than they were in March 2024 to say it’s a “major benefit” that people who come to the U.S. legally contribute to the economy and help American companies get the expertise of skilled workers. At the same time, perceptions of illegal immigration haven’t shifted meaningfully. Americans still see fewer benefits from people who come to the U.S. illegally.
Tylenol maker rebounds a day after unfounded claims about its safety
Shares of Tylenol maker Kenvue are bouncing back sharply before the opening bell a day after President Donald Trump promoted unproven and in some cases discredited ties between Tylenol, vaccines and autism. Trump told pregnant women not to use the painkiller around a dozen times during the White House news conference Monday. The drugmaker tumbled 7.5%. Shares have regained most of those losses early Tuesday in premarket trading.
Load More